Expert Opinion on Pharmacotherapy, Volume 23, Issue 7 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 23, Issue 7 (2022)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Volume 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Prescribing the right therapy for the treatment of chronic cough: a critical focus on current and investigational options
Paola Rogliani, Clive Page & Luigino Calzetta
Pages: 741-744
Published online: 03 Mar 2022
First Page PreviewforPrescribing the right therapy for the treatment of chronic cough: a critical focus on current and investigational options | Full Text | References | PDF (179.2 KB) | EPUB
  • 1476 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
What are the main considerations when prescribing pharmacotherapy for Parkinson’s disease?
Thomas Müller
Pages: 745-750
Published online: 25 Feb 2022
First Page PreviewforWhat are the main considerations when prescribing pharmacotherapy for Parkinson’s disease? | Full Text | References | PDF (814.6 KB) | EPUB
  • 1448 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
Ponatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia
Fadi G. Haddad, Ghayas C. Issa, Elias Jabbour & Musa Yilmaz
Pages: 751-758
Published online: 12 Apr 2022
AbstractforPonatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia | Full Text | References | PDF (292.1 KB) | EPUB
  • 421 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Tafenoquine for the treatment of Plasmodium vivax malaria
Alejandro Llanos-Cuentas, Paulo Manrrique, Angel Rosas-Aguirre, Sonia Herrera & Michelle S. Hsiang
Pages: 759-768
Published online: 13 Apr 2022
AbstractforTafenoquine for the treatment of Plasmodium vivax malaria | Full Text | References | PDF (1.3 MB) | EPUB
  • 2913 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Key Paper Evaluation

Article
Are there advantages of daprodustat over erythropoiesis-stimulating agents (ESAs) in treating anemia associated with chronic kidney disease (CKD)?
Sheila A Doggrell
Pages: 769-773
Published online: 05 Apr 2022
AbstractforAre there advantages of daprodustat over erythropoiesis-stimulating agents (ESAs) in treating anemia associated with chronic kidney disease (CKD)? | Full Text | References | PDF (188.5 KB) | EPUB
  • 490 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

The state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain
Ryan S. D’Souza, Brendan Langford, Rachel E. Wilson, Yeng F. Her, Justin Schappell, Jennifer S. Eller, Timothy C. Evans & Jonathan M. Hagedorn
Pages: 775-789
Published online: 04 Apr 2022
AbstractforThe state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain | Full Text | References | PDF (403.3 KB) | EPUB
  • 632 Views
  • 8 CrossRef citations
  • 0Altmetric
Recent advances in the pharmacotherapeutic management of diabetic kidney disease
Tomasz J. Block, Duygu Batu & Mark E. Cooper
Pages: 791-803
Published online: 06 May 2022
AbstractforRecent advances in the pharmacotherapeutic management of diabetic kidney disease | Full Text | References | PDF (971.6 KB) | EPUB
  • 387 Views
  • 3 CrossRef citations
  • 0Altmetric
Pharmacotherapy for mild traumatic brain injury: an overview of the current treatment options
Chuang Gao, Meng Nie, Jinhao Huang, Ye Tian, Dong Wang, Jianning Zhang & Rongcai Jiang
Pages: 805-813
Published online: 20 Mar 2022
AbstractforPharmacotherapy for mild traumatic brain injury: an overview of the current treatment options | Full Text | References | PDF (316.2 KB) | EPUB
  • 349 Views
  • 2 CrossRef citations
  • 0Altmetric
Met inhibitors in the treatment of lung cancer: the evidence to date
Gerhard Hamilton & Barbara Rath
Pages: 815-825
Published online: 13 Apr 2022
AbstractforMet inhibitors in the treatment of lung cancer: the evidence to date | Full Text | References | PDF (1.4 MB) | EPUB
  • 199 Views
  • 0 CrossRef citations
  • 0Altmetric
Drug treatment strategies for eosinophilic esophagitis in adults
Alfredo J Lucendo
Pages: 827-840
Published online: 04 Apr 2022
AbstractforDrug treatment strategies for eosinophilic esophagitis in adults | Full Text | References | PDF (414.7 KB) | EPUB
  • 539 Views
  • 0 CrossRef citations
  • 0Altmetric
A review of the pharmacotherapeutic considerations for managing epilepsy in people with autism
Lance V Watkins, Maire O’Dwyer & Rohit Shankar
Pages: 841-851
Published online: 28 Mar 2022
AbstractforA review of the pharmacotherapeutic considerations for managing epilepsy in people with autism | Full Text | References | PDF (897.4 KB) | EPUB
  • 4141 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Pharmacological management of severe plaque psoriasis in patients with cardiovascular disease
Stefano Piaserico & Francesco Messina
Pages: 853-864
Published online: 05 Apr 2022
AbstractforPharmacological management of severe plaque psoriasis in patients with cardiovascular disease | Full Text | References | PDF (435.6 KB) | EPUB
  • 258 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

A spotlight on using HIF-PH inhibitors in renal anemia
Motoki Odawara et al.
Report | Published online: 17 Jul 2024
Considerations when treating influenza infections with oseltamivir
Chunping Gu et al.
Review Article | Published online: 15 Jul 2024
The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis
María Caridad Mata Salvador et al.
Review Article | Published online: 11 Jul 2024
Advances in pharmacotherapy for sickle cell disease: what is the current state of play?
Sheinei Alan et al.
Review Article | Published online: 8 Jul 2024
View all latest articles